Folvite

Folic Acid Deficiency, Postpartum state, Folic Acid Deficiency + 7 more

Treatment

20 Active Studies for Folvite

What is Folvite

Folic acid

The Generic name of this drug

Treatment Summary

Folic acid, also known as folate or Vitamin B9, is an essential nutrient for the body. It helps with the production of DNA and RNA and is necessary for cell division. As people cannot produce folic acid on their own, it must be obtained from food sources such as green vegetables, beans, avocado, and some fruits. Folic acid is especially important for pregnant women to help prevent neural tube defects in newborns. It can also be supplemented to individuals using certain medications, such as antiepileptic drugs. Insufficient levels of folic acid can lead to cardiovascular disease, anemia, cognitive deficiencies, and

O-Cal FA multivitamin

is the brand name

image of different drug pills on a surface

Folvite Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

O-Cal FA multivitamin

Folic acid

1970

151

Effectiveness

How Folvite Affects Patients

Folic acid, also known as Vitamin B9 or folate, is an important vitamin found in foods like liver, kidney, and leafy green vegetables. It is necessary for the body to build and repair DNA and RNA, as well as to produce proteins. Folic acid is especially important in times of rapid cell division such as infancy, pregnancy, and erythropoiesis, and can help protect against cancer. Humans are not able to produce folic acid on their own, so it needs to be taken from food or supplements. In order for folic acid to work in the body, it is reduced by an enzyme

How Folvite works in the body

Folic acid helps the body in many different ways. To do this, it needs to be converted into active forms like tetrahydrofolic acid and methyltetrahydrofolate. These active forms are then transported into cells and used to synthesize important molecules like purines and thymidylate nucleic acids. Folic acid also helps the body convert homocysteine into methionine, which can help reduce high levels of homocysteine. Vitamin B12 is needed to help folic acid do this.

When to interrupt dosage

The measure of Folvite is contingent upon the diagnosed condition, including Pregnancy, Iron deficiency anemia and Iron deficiency. The measure fluctuates as per the method of delivery featured in the table beneath.

Condition

Dosage

Administration

Iron deficiency

, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg

Capsule, gelatin coated, , Oral, Tablet, Tablet - Oral, Tablet, film coated - Oral, Capsule - Oral, Capsule, Tablet, coated - Oral, Tablet, coated, Capsule, gelatin coated - Oral, Tablet, film coated, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Oral, Lozenge, Powder, Powder - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder, for solution - Oral, Lozenge - Oral, Powder, for solution, Solution / drops - Oral, Solution / drops, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Tablet, extended release, Liquid - Intravenous, Tablet, extended release - Oral, Solution - Oral, Solution, Capsule, extended release, Solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Capsule, extended release - Oral, Kit, Injection, solution - Intravenous, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Parenteral, Tablet, Delayed Release, Parenteral, Sublingual, Tablet, orally disintegrating, Tablet - Sublingual, Kit - Oral, Injection, powder, lyophilized, for solution, Wafer - Oral, Wafer, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Pill, Pill - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Solution - Intravenous, Patch, Transdermal, Capsule, coated - Oral, Patch - Transdermal, Capsule, coated, Strip, Strip - Oral, Bar, chewable - Oral, Bar, chewable, Injection, Injection - Intravenous

Nutritional supplementation

, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg

Capsule, gelatin coated, , Oral, Tablet, Tablet - Oral, Tablet, film coated - Oral, Capsule - Oral, Capsule, Tablet, coated - Oral, Tablet, coated, Capsule, gelatin coated - Oral, Tablet, film coated, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Oral, Lozenge, Powder, Powder - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder, for solution - Oral, Lozenge - Oral, Powder, for solution, Solution / drops - Oral, Solution / drops, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Tablet, extended release, Liquid - Intravenous, Tablet, extended release - Oral, Solution - Oral, Solution, Capsule, extended release, Solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Capsule, extended release - Oral, Kit, Injection, solution - Intravenous, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Parenteral, Tablet, Delayed Release, Parenteral, Sublingual, Tablet, orally disintegrating, Tablet - Sublingual, Kit - Oral, Injection, powder, lyophilized, for solution, Wafer - Oral, Wafer, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Pill, Pill - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Solution - Intravenous, Patch, Transdermal, Capsule, coated - Oral, Patch - Transdermal, Capsule, coated, Strip, Strip - Oral, Bar, chewable - Oral, Bar, chewable, Injection, Injection - Intravenous

Postpartum state

, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg

Capsule, gelatin coated, , Oral, Tablet, Tablet - Oral, Tablet, film coated - Oral, Capsule - Oral, Capsule, Tablet, coated - Oral, Tablet, coated, Capsule, gelatin coated - Oral, Tablet, film coated, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Oral, Lozenge, Powder, Powder - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder, for solution - Oral, Lozenge - Oral, Powder, for solution, Solution / drops - Oral, Solution / drops, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Tablet, extended release, Liquid - Intravenous, Tablet, extended release - Oral, Solution - Oral, Solution, Capsule, extended release, Solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Capsule, extended release - Oral, Kit, Injection, solution - Intravenous, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Parenteral, Tablet, Delayed Release, Parenteral, Sublingual, Tablet, orally disintegrating, Tablet - Sublingual, Kit - Oral, Injection, powder, lyophilized, for solution, Wafer - Oral, Wafer, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Pill, Pill - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Solution - Intravenous, Patch, Transdermal, Capsule, coated - Oral, Patch - Transdermal, Capsule, coated, Strip, Strip - Oral, Bar, chewable - Oral, Bar, chewable, Injection, Injection - Intravenous

Folic Acid Deficiency

, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg

Capsule, gelatin coated, , Oral, Tablet, Tablet - Oral, Tablet, film coated - Oral, Capsule - Oral, Capsule, Tablet, coated - Oral, Tablet, coated, Capsule, gelatin coated - Oral, Tablet, film coated, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Oral, Lozenge, Powder, Powder - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder, for solution - Oral, Lozenge - Oral, Powder, for solution, Solution / drops - Oral, Solution / drops, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Tablet, extended release, Liquid - Intravenous, Tablet, extended release - Oral, Solution - Oral, Solution, Capsule, extended release, Solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Capsule, extended release - Oral, Kit, Injection, solution - Intravenous, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Parenteral, Tablet, Delayed Release, Parenteral, Sublingual, Tablet, orally disintegrating, Tablet - Sublingual, Kit - Oral, Injection, powder, lyophilized, for solution, Wafer - Oral, Wafer, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Pill, Pill - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Solution - Intravenous, Patch, Transdermal, Capsule, coated - Oral, Patch - Transdermal, Capsule, coated, Strip, Strip - Oral, Bar, chewable - Oral, Bar, chewable, Injection, Injection - Intravenous

methotrexate toxicity

, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg

Capsule, gelatin coated, , Oral, Tablet, Tablet - Oral, Tablet, film coated - Oral, Capsule - Oral, Capsule, Tablet, coated - Oral, Tablet, coated, Capsule, gelatin coated - Oral, Tablet, film coated, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Oral, Lozenge, Powder, Powder - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder, for solution - Oral, Lozenge - Oral, Powder, for solution, Solution / drops - Oral, Solution / drops, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Tablet, extended release, Liquid - Intravenous, Tablet, extended release - Oral, Solution - Oral, Solution, Capsule, extended release, Solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Capsule, extended release - Oral, Kit, Injection, solution - Intravenous, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Parenteral, Tablet, Delayed Release, Parenteral, Sublingual, Tablet, orally disintegrating, Tablet - Sublingual, Kit - Oral, Injection, powder, lyophilized, for solution, Wafer - Oral, Wafer, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Pill, Pill - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Solution - Intravenous, Patch, Transdermal, Capsule, coated - Oral, Patch - Transdermal, Capsule, coated, Strip, Strip - Oral, Bar, chewable - Oral, Bar, chewable, Injection, Injection - Intravenous

Anemia, Iron-Deficiency

, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg

Capsule, gelatin coated, , Oral, Tablet, Tablet - Oral, Tablet, film coated - Oral, Capsule - Oral, Capsule, Tablet, coated - Oral, Tablet, coated, Capsule, gelatin coated - Oral, Tablet, film coated, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Oral, Lozenge, Powder, Powder - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder, for solution - Oral, Lozenge - Oral, Powder, for solution, Solution / drops - Oral, Solution / drops, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Tablet, extended release, Liquid - Intravenous, Tablet, extended release - Oral, Solution - Oral, Solution, Capsule, extended release, Solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Capsule, extended release - Oral, Kit, Injection, solution - Intravenous, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Parenteral, Tablet, Delayed Release, Parenteral, Sublingual, Tablet, orally disintegrating, Tablet - Sublingual, Kit - Oral, Injection, powder, lyophilized, for solution, Wafer - Oral, Wafer, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Pill, Pill - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Solution - Intravenous, Patch, Transdermal, Capsule, coated - Oral, Patch - Transdermal, Capsule, coated, Strip, Strip - Oral, Bar, chewable - Oral, Bar, chewable, Injection, Injection - Intravenous

Folic Acid Deficiency

, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg

Capsule, gelatin coated, , Oral, Tablet, Tablet - Oral, Tablet, film coated - Oral, Capsule - Oral, Capsule, Tablet, coated - Oral, Tablet, coated, Capsule, gelatin coated - Oral, Tablet, film coated, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Oral, Lozenge, Powder, Powder - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder, for solution - Oral, Lozenge - Oral, Powder, for solution, Solution / drops - Oral, Solution / drops, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Tablet, extended release, Liquid - Intravenous, Tablet, extended release - Oral, Solution - Oral, Solution, Capsule, extended release, Solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Capsule, extended release - Oral, Kit, Injection, solution - Intravenous, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Parenteral, Tablet, Delayed Release, Parenteral, Sublingual, Tablet, orally disintegrating, Tablet - Sublingual, Kit - Oral, Injection, powder, lyophilized, for solution, Wafer - Oral, Wafer, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Pill, Pill - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Solution - Intravenous, Patch, Transdermal, Capsule, coated - Oral, Patch - Transdermal, Capsule, coated, Strip, Strip - Oral, Bar, chewable - Oral, Bar, chewable, Injection, Injection - Intravenous

Iron Deficiency Anemia

, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg

Capsule, gelatin coated, , Oral, Tablet, Tablet - Oral, Tablet, film coated - Oral, Capsule - Oral, Capsule, Tablet, coated - Oral, Tablet, coated, Capsule, gelatin coated - Oral, Tablet, film coated, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Oral, Lozenge, Powder, Powder - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder, for solution - Oral, Lozenge - Oral, Powder, for solution, Solution / drops - Oral, Solution / drops, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Tablet, extended release, Liquid - Intravenous, Tablet, extended release - Oral, Solution - Oral, Solution, Capsule, extended release, Solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Capsule, extended release - Oral, Kit, Injection, solution - Intravenous, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Parenteral, Tablet, Delayed Release, Parenteral, Sublingual, Tablet, orally disintegrating, Tablet - Sublingual, Kit - Oral, Injection, powder, lyophilized, for solution, Wafer - Oral, Wafer, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Pill, Pill - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Solution - Intravenous, Patch, Transdermal, Capsule, coated - Oral, Patch - Transdermal, Capsule, coated, Strip, Strip - Oral, Bar, chewable - Oral, Bar, chewable, Injection, Injection - Intravenous

N-Cadherins

, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg

Capsule, gelatin coated, , Oral, Tablet, Tablet - Oral, Tablet, film coated - Oral, Capsule - Oral, Capsule, Tablet, coated - Oral, Tablet, coated, Capsule, gelatin coated - Oral, Tablet, film coated, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Oral, Lozenge, Powder, Powder - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder, for solution - Oral, Lozenge - Oral, Powder, for solution, Solution / drops - Oral, Solution / drops, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Tablet, extended release, Liquid - Intravenous, Tablet, extended release - Oral, Solution - Oral, Solution, Capsule, extended release, Solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Capsule, extended release - Oral, Kit, Injection, solution - Intravenous, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Parenteral, Tablet, Delayed Release, Parenteral, Sublingual, Tablet, orally disintegrating, Tablet - Sublingual, Kit - Oral, Injection, powder, lyophilized, for solution, Wafer - Oral, Wafer, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Pill, Pill - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Solution - Intravenous, Patch, Transdermal, Capsule, coated - Oral, Patch - Transdermal, Capsule, coated, Strip, Strip - Oral, Bar, chewable - Oral, Bar, chewable, Injection, Injection - Intravenous

Avitaminosis

, 1.0 mg, 1.22 mg, 1.2 mg, 1.25 mg, 0.4 mg, 2.5 mg, 0.1 mg, 0.25 mg, 0.03 mg, 10.0 mg, 0.5 mg, 2.2 mg, 1.0 mg/mg, 5.0 mg, 25.0 mg, 0.8 mg, 0.2 mg, 133.3 mg, 0.05 mg, 0.3 mg, 0.025 mg, 0.133 mg, 0.095 mg, 0.375 mg, 0.8 mg/mg, 5.0 mg/mL, 1.24 mg, 2.3 mg, 1.1 mg, 2.0 mg, 20.0 mg, 1.67 mg, 0.04 mg, 1.4 mg, 0.14 mg/mL, 3.0 mg, 42.5 mg, 0.06 mg/mL, 2.8 mg, 0.6 mg/mL, 1.0 mg/mL, 0.14 mg, 0.0667 mg, 0.32 mg, 0.067 mg, 0.267 mg, 0.01 mg, 0.13 mg, 5.2 mg, 0.052 mg, 0.0666 mg, 0.033 mg, 0.285 mg, 0.013 mg, 0.007 mg, 4.0 mg, 0.6 mg, 0.125 mg, 0.33 mg, 0.333 mg, 0.13337 mg, 0.08 mg, 0.0133 mg, 1.667 mg, 0.0004 mg, 0.7 mg, 0.15 mg, 0.2 mg/mg, 0.838 mg, 0.07 mg, 0.26 mg, 0.022 mg, 0.13333 mg, 0.0065 mg, 0.999 mg, 1.66 mg, 0.096 mg, 0.06 mg, 0.00025 mg/mg, 0.0025 mg/mg, 0.066 mg, 0.0002 mg/mg, 0.048 mg/mL, 0.00055 mg/mL, 0.4 mg/mL, 0.0005 mg/mL, 0.04 mg/mL, 0.68 mg, 0.0004 mg/mg, 0.02 mg/mL, 0.1 mg/mL, 0.00002 mg/mg, 0.00012 mg/mg, 0.000026 mg/mg, 0.00004 mg/mg, 0.014 mg/mL, 0.000002 mg/mg, 0.000014 mg/mg, 0.08 mg/mL, 0.000048 mg/mg, 0.007 mg/mL, 0.0001 mg/mg, 0.2 mg/mL, 0.027 mg/mL, 0.00013 mg/mg, 0.01 mg/mL, 0.85 mg, 680.0 mg, 1.7 mg

Capsule, gelatin coated, , Oral, Tablet, Tablet - Oral, Tablet, film coated - Oral, Capsule - Oral, Capsule, Tablet, coated - Oral, Tablet, coated, Capsule, gelatin coated - Oral, Tablet, film coated, Liquid - Intramuscular; Intravenous; Subcutaneous, Intramuscular; Intravenous; Subcutaneous, Liquid, Liquid - Oral, Lozenge, Powder, Powder - Oral, Tablet, chewable, Tablet, chewable - Oral, Capsule, liquid filled, Capsule, liquid filled - Oral, Powder, for solution - Oral, Lozenge - Oral, Powder, for solution, Solution / drops - Oral, Solution / drops, Intravenous, Injection, powder, lyophilized, for solution - Intravenous, Tablet, extended release, Liquid - Intravenous, Tablet, extended release - Oral, Solution - Oral, Solution, Capsule, extended release, Solution - Intramuscular; Intravenous; Subcutaneous, Injection, solution, Injection, solution - Intramuscular; Intravenous; Subcutaneous, Capsule, extended release - Oral, Kit, Injection, solution - Intravenous, Tablet, orally disintegrating - Oral, Tablet, Delayed Release - Oral, Solution - Parenteral, Tablet, Delayed Release, Parenteral, Sublingual, Tablet, orally disintegrating, Tablet - Sublingual, Kit - Oral, Injection, powder, lyophilized, for solution, Wafer - Oral, Wafer, Capsule, delayed release pellets, Capsule, delayed release pellets - Oral, Pill, Pill - Oral, Tablet, effervescent, Tablet, effervescent - Oral, Granule, effervescent, Granule, effervescent - Oral, Solution - Intravenous, Patch, Transdermal, Capsule, coated - Oral, Patch - Transdermal, Capsule, coated, Strip, Strip - Oral, Bar, chewable - Oral, Bar, chewable, Injection, Injection - Intravenous

Warnings

There are 20 known major drug interactions with Folvite.

Common Folvite Drug Interactions

Drug Name

Risk Level

Description

5-fluorouridine

Major

The risk or severity of adverse effects can be increased when Folic acid is combined with 5-fluorouridine.

Capecitabine

Major

The risk or severity of adverse effects can be increased when Folic acid is combined with Capecitabine.

Doxifluridine

Major

The risk or severity of adverse effects can be increased when Folic acid is combined with Doxifluridine.

Flucytosine

Major

The risk or severity of adverse effects can be increased when Folic acid is combined with Flucytosine.

Fluorouracil

Major

The risk or severity of adverse effects can be increased when Folic acid is combined with Fluorouracil.

Folvite Toxicity & Overdose Risk

The lowest toxic dose of IPR-MUS in rats is 85mg/kg, IVN-GPG is 120mg/kg, IVN-MUS is 239mg/kg, IVN-RAT is 500mg/kg, and IVN-RBT is 410mg/kg.

Folvite Novel Uses: Which Conditions Have a Clinical Trial Featuring Folvite?

76 active studies are being conducted to assess the potential of Folvite in managing Iron deficiency anemia, Pregnancy and Postpartum states.

Condition

Clinical Trials

Trial Phases

Nutritional supplementation

1 Actively Recruiting

Early Phase 1

Folic Acid Deficiency

0 Actively Recruiting

Postpartum state

14 Actively Recruiting

Not Applicable, Phase 4, Phase 1

N-Cadherins

0 Actively Recruiting

Avitaminosis

1 Actively Recruiting

Not Applicable

Anemia, Iron-Deficiency

0 Actively Recruiting

Folic Acid Deficiency

0 Actively Recruiting

methotrexate toxicity

0 Actively Recruiting

Iron deficiency

5 Actively Recruiting

Phase 2, Not Applicable, Phase 4, Early Phase 1, Phase 3

Iron Deficiency Anemia

8 Actively Recruiting

Phase 3, Phase 4, Phase 2, Not Applicable

Patient Q&A Section about folvite

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is Folvite a vitamin Tablet?

"Folvite is a vitamin that is available both over the counter and by prescription. It is used as a nutritional supplement to prevent Neural Tube Defects and Folic Acid deficiency, and as a treatment for methanol toxicity. Folvite can be used alone or with other medications."

Answered by AI

What is Folvite used for?

"Folic acid supplements are taken to treat or prevent low folate levels, which can lead to anemia. Low folate levels can be caused by conditions such as poor diet, pregnancy, alcoholism, liver disease, and certain stomach/intestinal problems."

Answered by AI

When should Folvite be taken?

"Folvite 5mg Tablet can be taken at any time of day, but it is best to take it at the same time each day to help remember. Take as prescribed by your doctor. Swallow the medicine whole with a glass of water."

Answered by AI

What is the difference between folic acid and Folvite?

"Folate is a natural form of vitamin B9 found in food, while folic acid is a synthetic form. High intake of folic acid can lead to increased blood levels of unmetabolized folic acid."

Answered by AI

Clinical Trials for Folvite

Image of University of California San Diego in La Jolla, United States.

AI Chatbot for Postpartum Loneliness

18+
Female
La Jolla, CA

The goal of this clinical trial is to learn whether a postpartum chatbot powered by generative artificial intelligence (genAI) can help new mothers get better pelvic floor health information and feel less lonely after childbirth. The main questions this study aims to answer are: * Does using the chatbot improve postpartum pelvic floor health knowledge? * Does using the chatbot help reduce feelings of loneliness during the postpartum period? * Does using the chatbot impact pelvic floor symptoms? Researchers will compare standard postpartum care to standard care plus the chatbot. Participants will: Be assigned by chance (like flipping a coin) to standard postpartum care with or without access to the chatbot. If in the chatbot group, participants will receive education and support via the chatbot over a 4-week period. Both groups will complete questionnaires to measure their pelvic floor knowledge, pelvic floor symptoms, feelings of loneliness, depression, infant bonding, perceived social support, adverse childhood experiences, and peri-traumatic distress. The chatbot was created by urogynecology experts in collaboration with UC San Diego computer science and biomedical informatics researchers. The chatbot is designed to give new mothers personalized, evidence-based information and support in real time.

Waitlist Available
Has No Placebo

University of California San Diego

Image of Columbia University Irving Medical Center in New York, United States.

Intravenous Iron for Iron Deficiency in Scoliosis

10 - 19
All Sexes
New York, NY

Adolescents and young adults undergoing spinal fusion surgery for the correction of scoliosis and other spinal deformity are at high risk of perioperative iron deficiency and anemia, yet the means and evidence for optimizing iron status have not been described in this setting. The proposed study is a randomized controlled trial of preoperative intravenous iron supplementation, to identify whether iron deficiency is a modifiable risk factor for adverse surgical outcomes such as red blood cell transfusion and diminished postoperative cognitive and physical capacity in this vulnerable population. Building evidence for patient blood management interventions such as iron supplementation is vital to ensuring high quality care of surgical patients and may reduce unnecessary transfusions amid recent blood shortages.

Phase 2 & 3
Recruiting

Columbia University Irving Medical Center

Have you considered Folvite clinical trials?

We made a collection of clinical trials featuring Folvite, we think they might fit your search criteria.
Go to Trials
Image of Madigan Army Medical Center in Tacoma, United States.

Vitamin D3 + K2 for Vitamin Deficiency

18 - 69
All Sexes
Tacoma, WA

The main purpose of this research study is to learn about the effects of supplemental vitamin D3 and vitamin K2 on blood levels and the gut microbial community, called the gut microbiome. There are many influences on blood levels of vitamin D and K to include your dietary intake, lifestyle behaviors (physical activity, sleep), genetic alterations in metabolism of these vitamins, and the gut microbial abundance and diversity. You will be asked to take one capsule containing vitamin D3 (125 mcg), vitamin K2 (180 mcg), a combination of vitamins D3 and K2 (same doses as previous), or a placebo powder for 90 days. You will also be asked to complete questionnaires, undergo body composition and blood pressure measurements, provide blood samples and a stool swab, all on 2 occasions about 3 - 4 months apart. By conducting this study, we aim to identify the frequency of common genetic alterations in vitamins D and K metabolism and establish the impact on the gut microbiome for the first time. Your participation in this study will last about 4 - 6 months and include up to 3 visits.

Recruiting
Paid Trial

Madigan Army Medical Center

Mary S McCarthy, PhD

Image of Centre hospitalier affilié universitaire régional de Trois-Rivières in Trois-Rivières, Canada.

Endoscopic Evaluation for Iron-Deficiency Anemia

18 - 90
All Sexes
Trois-Rivières, Canada

This is a single-center, randomized pilot study evaluating the feasibility and safety of two management strategies for patients on antithrombotic therapy who present with obscure gastrointestinal bleeding (OGIB). Participants will be randomized to either repeated endoscopic evaluations or a conservative medical approach with limited testing. The study aims to assess whether conservative management yields similar clinical outcomes and quality of life compared to standard repeated endoscopic procedures. Results will inform the design of a larger trial and address the current lack of guidelines for managing recurrent iron-deficiency anemia in this patient population.

Recruiting
Has No Placebo

Centre hospitalier affilié universitaire régional de Trois-Rivières

Éva Mathieu, PhD

Image of University of Calgary in Calgary, Canada.

Iron Supplementation for Iron Deficiency

18 - 40
Female
Calgary, Canada

The goal of this clinical trial is to learn whether oral iron supplementation will increase skeletal muscle iron storage and its effects on exercise capacity in females with suboptimal iron status. The study will include healthy females, ages 18-40, who either have suboptimal or optimal iron stores. The main questions it aims to answer are: * Does iron supplementation increase skeletal muscle iron storage and alter the expression of iron-related and mitochondrial proteins? * Does iron supplementation improve single-leg exercise performance? * Is serum ferritin correlated with the abundance of iron-related proteins in skeletal muscle? Researchers will compare outcomes from females with suboptimal iron status who receive oral iron supplementation to those who receive a placebo to see if supplementation improves muscle iron storage, protein expression, and exercise performance. Additionally, a non-intervention control group with optimal iron status will be included to assess baseline differences. Participants will: \- Be randomly assigned to receive 150 mg elemental iron or placebo (maltodextrin) every other day for 12 weeks Complete pre- and post-supplementation testing, including: * Blood draws to assess iron status * Skeletal muscle biopsies to analyze protein content * Whole-body and single-leg exercise tests to assess performance * Controls will undergo baseline-only testing to compare physiological and biochemical markers

Phase < 1
Waitlist Available

University of Calgary

Martin J MacInnis

Image of Women's College Hospital in Toronto, Canada.

MOVIN Care Platform for Postpartum Depression

18+
Female
Toronto, Canada

Depression, anxiety, and related disorders such as post-traumatic stress and obsessive compulsive disorder affect about 20% of pregnant and postpartum people. When not treated properly, these issues negatively impact not only affected people, but also their children's health and development. Only 1 in 5 receive adequate treatment, so identifying new system-wide approaches to reliably deliver recommended care to perinatal mental health patients all is a crucial health care priority. The Pregnancy and Postpartum Mental health Optimization Virtual Intervention Network (MOVIN) is a scalable perinatal mental health platform building on the evidence-based Collaborative care delivery model. MOVIN's online platform allows patients to connect with a care coordinator to co-develop personalized treatment recommendations, in collaboration with their primary care clinician and a perinatal psychiatrist when needed; progress is tracked to re-evaluate.

Recruiting
Has No Placebo

Women's College Hospital

Have you considered Folvite clinical trials?

We made a collection of clinical trials featuring Folvite, we think they might fit your search criteria.
Go to Trials
Image of The Medical Center in Bowling Green, United States.

Iron Supplementation for Heart Failure

18 - 100
All Sexes
Bowling Green, KY

The goal of this clinical trial is to learn which iron treatment works better for adults with congestive heart failure and low iron levels: intravenous (IV) iron given through a vein or oral (PO) iron taken by mouth. Participants must have heart failure with reduced ejection fraction (HFrEF) or preserved ejection fraction (HFpEF) and a transferrin-saturation (TSAT) level below 20 percent. The main questions the study will answer are: 1. Does IV iron raise walking distance on a 6-minute walk test more than oral iron after 24 weeks? 2. Does IV iron improve symptoms and quality of life more than oral iron? 3. How do the two treatments compare for safety, side effects, and hospital readmissions/ mortality? Researchers will compare IV ferric carboxymaltose with oral ferrous sulfate to see which option helps people feel and function better. What participants will do * Be randomly assigned by (like flipping a coin) to IV iron or oral iron. * Receive either a one-time IV iron infusion (with possible repeat at 12 weeks) or take iron pills twice each day for 24 weeks. * Visit the infusion clinic at 6 weeks for second dose of IV iron if needed. * Visit the clinic at 12 weeks for a follow-up to gather follow-up data including 1. A 6-minute walk test 2. Brief symptom and quality-of-life surveys 3. Blood tests to measure serum iron, ferritin, and transferrin saturation This study will help doctors decide whether IV or oral iron is the safer, more effective way to treat iron deficiency in people with heart failure in our local community.

Phase 4
Recruiting

The Medical Center

American Regent, Inc.

Image of University of Calgary in Calgary, Canada.

Iron Supplements for Iron Deficiency

16 - 35
Female
Calgary, Canada

The goal of this clinical trial is to learn if different types and doses of oral iron supplements can improve iron levels, athletic performance, and gut health in young female athletes with low iron stores. The main questions it aims to answer are: * Does a low dose of yeast-bound iron improve iron status better than traditional iron supplements? * Do the different iron supplements cause fewer or more gastrointestinal (stomach) symptoms? * How do iron supplements affect exercise performance and gut bacteria? Researchers will compare three types of iron supplements: * A low-dose iron supplement (40 mg) * A low-dose yeast-bound iron supplement (40 mg) * A high-dose iron supplement (150 mg) This will help researchers find out which type of supplement is most effective and easiest on the stomach. Participants will: * Take one of the three assigned iron supplements every other day for 12 weeks * Complete fitness tests before and after the study, including cycling and jumping tests * Give blood samples to measure iron levels * Provide stool and intestinal samples to study gut bacteria * Swallow a SIMBA capsule before and after the study to collect a sample from the small intestine * Complete regular online surveys about sleep, stress, menstrual cycles, and gut symptoms

Waitlist Available
Has No Placebo

University of Calgary

Jane Shearer

Mitacs

Have you considered Folvite clinical trials?

We made a collection of clinical trials featuring Folvite, we think they might fit your search criteria.
Go to Trials